.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Novartis
Citi
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance
Boehringer Ingelheim
Chinese Patent Office
Daiichi Sankyo
Mallinckrodt

Generated: June 23, 2017

DrugPatentWatch Database Preview

Candesartan cilexetil; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic sources for candesartan cilexetil; hydrochlorothiazide and what is the scope of candesartan cilexetil; hydrochlorothiazide patent protection?

Candesartan cilexetil; hydrochlorothiazide
is the generic ingredient in two branded drugs marketed by Macleods Pharms Ltd, Mylan Pharms Inc, Dr Reddys Labs Ltd, Apotex Inc, and Astrazeneca, and is included in five NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for candesartan cilexetil; hydrochlorothiazide. Six suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: candesartan cilexetil; hydrochlorothiazide

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list22
Suppliers / Packagers: see list6
Bulk Api Vendors: see list1
Clinical Trials: see list424
Patent Applications: see list2
Drug Prices:see low prices
DailyMed Link:candesartan cilexetil; hydrochlorothiazide at DailyMed

Pharmacology for Ingredient: candesartan cilexetil; hydrochlorothiazide

Tentative approvals for CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe16MG; 12.5MGTABLET; ORAL
► Subscribe► Subscribe32MG; 25MGTABLET; ORAL
► Subscribe► Subscribe32MG; 12.5MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-001Sep 5, 2000ABRXYesNo► Subscribe► Subscribe
Mylan Pharms Inc
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL090704-001Dec 4, 2012ABRXNoNo► Subscribe► Subscribe
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-002Sep 5, 2000ABRXYesNo► Subscribe► Subscribe
Macleods Pharms Ltd
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL204100-001Feb 27, 2015ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL090704-003Dec 4, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: candesartan cilexetil; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-001Sep 5, 20005,705,517*PED► Subscribe
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-003May 16, 20085,196,444*PED► Subscribe
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-001Sep 5, 20005,958,961► Subscribe
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-001Sep 5, 20007,538,133*PED► Subscribe
Astrazeneca
ATACAND HCT
candesartan cilexetil; hydrochlorothiazide
TABLET;ORAL021093-001Sep 5, 20005,196,444*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Boehringer Ingelheim
Cipla
Daiichi Sankyo
McKinsey
Chubb
Fish and Richardson
AstraZeneca
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot